Michael York - 26 Jan 2023 Form 4 Insider Report for Metacrine, Inc.

Reporting relationship: Chief Business Officer
Issuer ticker: N/A
Reported as of: 26 Jan 2023
Net transaction value: -$44,331
SEC form: 4
Accepted by SEC: 27 Jan 2023, 15:44:04 UTC
Prior SEC filing: 01 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael York

Key filing fact

Michael York filed Form 4 for Metacrine, Inc. on 27 Jan 2023.

Key facts

This page summarizes Michael York's Form 4 filing for Metacrine, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Jan 2023, 15:44.

Change

Previous filing in this sequence was filed on 01 Mar 2022.
Current net transaction value: -$44,331.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MTCR transaction

Common Stock

Sale

Transaction value: $44,331
Shares: -107,054
Change %: -51%
Price: $0.4141
Shares after: 103,499
Date: 26 Jan 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Sale of shares to cover tax withholding obligations associated with the vesting of the restricted stock unit award granted to the Reporting Person on February 27, 2022.

Footnote F2

The price reported in Column 4 is an average weighted sales price. These shares were sold in multiple transactions at prices ranging from $.4114 to $.4501, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.